Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Helman

Showing results (91-100 of 211) with videos related to

Pageof 22
Sort By:
The Journal of Clinical Endocrinology and Metabolism|June 1, 1990
Expression of chromogranin-A messenger ribonucleic acid in parathyroid tissue from patients with primary hyperparathyroidismM A Levine, M A Dempsey, L J Helman, et al.
Sarcoma|June 4, 2008
Molecular alterations in pediatric sarcomas: potential targets for immunotherapyT J Goletz, C L Mackall, J A Berzofsky, et al.
Sarcoma|June 4, 2008
Autocrine Transforming Growth Factor-beta Growth Pathway in Murine Osteosarcoma Cell Lines Associated with Inability to Affect Phosphorylation of Retinoblastoma ProteinF Navid, J J Letterio, C L Yeung, et al.
The European Journal of Neuroscience|June 28, 2022
Central and cardiac stress resilience consistently linked to integrated immuno-neuroendocrine responses across stress models in male miceTessa J Helman, John P Headrick, Jason N Peart, et al.
Oral Surgery, Oral Medicine, and Oral Pathology|December 1, 1985
Nonspecific immunity and head and neck cancer: blastogenesis reviewed and revisitedD P Eskinazi, J Helman, A G Ershow, et al.
Invasion & Metastasis|January 1, 1996
Metastatic human rhabdomyosarcoma: molecular, cellular and cytogenetic analysis of a novel cellular modelT Kalebic, J G Judde, M Velez-Yanguas, et al.
Medical and Pediatric Oncology|March 1, 2000
Inguinal hernia in patients with Ewing sarcoma: a clue to etiologyJ U Cope, M Tsokos, L J Helman, et al.
International Journal of Cancer|April 16, 1998
Expression of a kinase-deficient IGF-I-R suppresses tumorigenicity of rhabdomyosarcoma cells constitutively expressing a wild type IGF-I-RT Kalebic, V Blakesley, C Slade, et al.
The Journal of Endocrinology|March 1, 1997
Role of the IGF-I receptor in mutagenesis and tumor promotionV A Blakesley, B S Stannard, T Kalebic, et al.
Pediatric Blood & Cancer|October 16, 2020
LRRC15 antibody-drug conjugates show promise as osteosarcoma therapeutics in preclinical studiesKatherine K Slemmons, Sanjit Mukherjee, Paul Meltzer, et al.
Pageof 22

Showing results (91-100 of 211) with videos related to

Sort By:
Pageof 22
The Journal of Clinical Endocrinology and Metabolism|June 1, 1990
Expression of chromogranin-A messenger ribonucleic acid in parathyroid tissue from patients with primary hyperparathyroidismM A Levine, M A Dempsey, L J Helman, et al.
Sarcoma|June 4, 2008
Molecular alterations in pediatric sarcomas: potential targets for immunotherapyT J Goletz, C L Mackall, J A Berzofsky, et al.
Sarcoma|June 4, 2008
Autocrine Transforming Growth Factor-beta Growth Pathway in Murine Osteosarcoma Cell Lines Associated with Inability to Affect Phosphorylation of Retinoblastoma ProteinF Navid, J J Letterio, C L Yeung, et al.
The European Journal of Neuroscience|June 28, 2022
Central and cardiac stress resilience consistently linked to integrated immuno-neuroendocrine responses across stress models in male miceTessa J Helman, John P Headrick, Jason N Peart, et al.
Oral Surgery, Oral Medicine, and Oral Pathology|December 1, 1985
Nonspecific immunity and head and neck cancer: blastogenesis reviewed and revisitedD P Eskinazi, J Helman, A G Ershow, et al.
Invasion & Metastasis|January 1, 1996
Metastatic human rhabdomyosarcoma: molecular, cellular and cytogenetic analysis of a novel cellular modelT Kalebic, J G Judde, M Velez-Yanguas, et al.
Medical and Pediatric Oncology|March 1, 2000
Inguinal hernia in patients with Ewing sarcoma: a clue to etiologyJ U Cope, M Tsokos, L J Helman, et al.
International Journal of Cancer|April 16, 1998
Expression of a kinase-deficient IGF-I-R suppresses tumorigenicity of rhabdomyosarcoma cells constitutively expressing a wild type IGF-I-RT Kalebic, V Blakesley, C Slade, et al.
The Journal of Endocrinology|March 1, 1997
Role of the IGF-I receptor in mutagenesis and tumor promotionV A Blakesley, B S Stannard, T Kalebic, et al.
Pediatric Blood & Cancer|October 16, 2020
LRRC15 antibody-drug conjugates show promise as osteosarcoma therapeutics in preclinical studiesKatherine K Slemmons, Sanjit Mukherjee, Paul Meltzer, et al.
Pageof 22